Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

October 25, 2024

Study Completion Date

October 25, 2024

Conditions
Severe Asthma
Trial Locations (14)

Unknown

Research Site, Alcázar de San Juan

Research Site, Almería

Research Site, Badajoz

Research Site, Bilbao

Research Site, Coslada

Research Site, Donostia / San Sebastian

Research Site, Fuenlabrada

Research Site, Gran Canaria

Research Site, Lugo

Research Site, Madrid

Research Site, Málaga

Research Site, Talavera de la Reina

Research Site, Torrejón de Ardoz

Research Site, Valencia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY